ArticleThe World Allergy Organization journal2022

Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma.

Georg Bölke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.